Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice

Patients with asthma frequently over rely on short-acting beta-agonists (SABA) to treat acute symptoms. This can adversely impact quality of life and increase the risk of exacerbations. SABA overuse is also associated with an increased risk of mortality. In their 2021 update on the diagnosis and man...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Anne K., Foran, Vanessa, Kaplan, Alan, Mitchell, Patrick D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188246/
https://www.ncbi.nlm.nih.gov/pubmed/35690850
http://dx.doi.org/10.1186/s13223-022-00690-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188246/
https://www.ncbi.nlm.nih.gov/pubmed/35690850
http://dx.doi.org/10.1186/s13223-022-00690-2

Ejemplares similares